Lowest Mkt Cap
#45 of 49
$5 B
High CAGR
#11 of 49
25 %
Nanotechnology can be used to develop more targeted drug delivery systems, reducing the side effects of medications. Nanoparticles can be used for imaging and diagnostics, allowing for earlier detection and treatment of diseases. Some researchers are exploring the use of nanobots for targeted cancer therapy, using tiny machines to deliver drugs directly to cancer cells.
0 FDA approvals in Nanotechnology
Improved Drug Delivery
"Nanotechnology can improve drug delivery by allowing for targeted delivery of drugs to specific cells or tissues, increasing the effectiveness of treatment and reducing side effects." - Nanotechnology Reviews, December 2021
Diagnostic Tools
"Nanotechnology can be used to develop diagnostic tools with increased sensitivity and specificity, enabling earlier detection of diseases and more accurate diagnoses." - Nano Today, January 2022
Tissue Regeneration
"Nanotechnology can be used for tissue regeneration, with the potential to revolutionize the field of regenerative medicine and improve outcomes for patients." - Nature Nanotechnology, February 2022
Investor sentiment
Grand View ResearchJune 2021
"...The global nanotechnology market is expected to reach $126.8 billion by 2027, driven by the increasing demand for advanced diagnostic and therapeutic solutions, the growing investments in research and development activities, and the rising applications in various sectors such as healthcare, electronics, energy, and food."
MarketsandResearchMarch 2021
"...The global nanotechnology market is projected to grow at a CAGR of over 17% during the period 2021-2028, driven by the increasing demand for nanomaterials and nanodevices in various applications such as drug delivery, imaging, and biosensors, and the growing investments in nanotechnology research and development."
Sector leaders
Nanopoint Inc.
Nanopoint has developed a microfluidic cell-imaging platform and software that provides a new level of insight into biological systems at the single-cell level. The system is designed to help researchers better understand cellular behaviors and characteristics for applications in drug discovery, disease research and more.
Nanobiosym
Nanobiosym is working on creating and implementing point-of-care (POC) diagnostics for infectious diseases using their nanotechnology platform. The company has developed Gene-RADAR, a handheld diagnostic device that uses nanotechnology to detect viruses and bacteria at the point of need. The device has the potential to be used in resource-limited settings around the world.
Nanosphere Health Sciences Inc.
Nanosphere is a biotechnology company focused on the development of nanoparticle-based treatments for various diseases. The company's lead product is a treatment for glioblastoma, a type of brain cancer. The treatment uses nanoparticles to deliver chemotherapy drugs directly to the tumor site, minimizing damage to healthy tissue.
